Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2057-2062

  Kim, Jeong Hun ^a,b,c   Song, Hyun Beom ^a,b,c   Park, Kyung Duk ^b   Kim, Jin Hyoung ^a,c   Kim, Dong Hun ^d   Yu, Young Suk ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Tumor Microenvironment Research Center   (South Korea)

^d Chosun University   (South Korea)

Author keywords

Angiogenesis; Extracellular signal regulated kinase; Retinoblastoma; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ANIMALS; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RETINOBLASTOMA; THROMBOPLASTIN;

EID: 84868142196     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2048     Document Type: Conference Paper

References (29)

1. Broaddus E, Topham A and Singh AD: Incidence of retinoblastoma in the USA:1975-2004. Br J Ophthalmol 93:21-23, 2009.
2. Burnier MN, McLean IW, Zimmerman LE and Rosenberg SH: Retinoblastoma. The relationship of proliferating cells to blood vessels. Invest Ophthalmol Vis Sci 31:2037-2040, 1990. (Pubitemid 20355815)
3. Marback EF, Arias VE, Paranhos A Jr, Soares FA, Murphree AL and Erwenne CM: Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol 87:1224-1228, 2003. (Pubitemid 37193910)
4. Rubin CM, Robison LL, Cameron JD, et al: Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol 3:680-685, 1985. (Pubitemid 15119241)
5. Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY and Chevez-Barrios P: Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 130:1669-1672, 2006. (Pubitemid 44683795)
6. Falanga A: Thrombophilia in cancer. Semin Thromb Hemost 31:104-110, 2005. (Pubitemid 40262144)
7. Schaffner F and Ruf W: Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol 29:1999-2004, 2009.
8. Van Den Berg YW, Osanto S, Reitsma PH and Versteeg HH: The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 119:924-932, 2012.
9. Khorana AA, Ahrendt SA, Ryan CK, et al: Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13:2870-2875, 2007. (Pubitemid 46849560)
10. Lopez-Pedrera C, Barbarroja N, Dorado G, Siendones E and Velasco F: Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies. Leukemia 20:1331-1340, 2006. (Pubitemid 44084043)
11. Contrino J, Hair G, Kreutzer DL and Rickles FR: In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 2:209-215, 1996. (Pubitemid 26054985)
12. Lwaleed BA and Bass PS: Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 208:327-339, 2006. (Pubitemid 43210519)
13. Lee BJ, Kim JH, Woo SH, Kim DH and Yu YS: Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways. Oncol Rep 26:665-670, 2011.
14. Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ and Kim KW: Establishment and characterization of a novel, spontaneously immortalized retinoblastoma cell line with adherent growth. Int J Oncol 31:585-592, 2007.
15. Jun. HO, Kim Y, Kwon YW, et al: Wondonin, a novel compound, inhibits hypoxia-induced angiogenesis through hypoxia-inducible factor 1 alpha. FEBS Lett 581:4977-4982, 2007. (Pubitemid 47542269)
16. Lim Y, Jo DH, Kim JH, et al: Human apolipoprotein (a) kringle V inhibits ischemia-induced retinal neovascularization via suppression of fibronectin-mediated angiogenesis. Diabetes 61:1599-1608, 2012.
17. Min JK, Cho YL, Choi JH, et al: Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 109:1495-1502, 2007.
18. Schweigerer L, Neufeld G and Gospodarowicz D: Basic fbroblast growth factor is present in cultured human retinoblastoma cells. Invest Ophthalmol Vis Sci 28:1838-1843, 1987. (Pubitemid 17165764)
19. Eliceiri BP, Klemke R, Strömblad S and Cheresh DA: Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140:1255-1263, 1998. (Pubitemid 28128883)
20. Callander NS, Varki N and Rao LV: Immunohistochemical identification of tissue factor in solid tumors. Cancer 70:1194-1201, 1992.
21. Saito T, Koyama T, Nagata K, Kamiyama R and Hirosawa S: Anticoagulant effects of retinoic acids on leukemia cells. Blood 87:657-665, 1996. (Pubitemid 26030321)
22. Zunyan D, Ying H and Sadee W: Growth factor signaling and resistance to cancer chemotherapy. Curr Topic Med Chem 4:1345-1354, 2004.
23. Cebulla CM, Jockovich ME, Piña Y, et al: Basic fibroblast growth factor impact on retinoblastoma progression and survival. Invest Ophthalmol Vis Sci 49:5215-5221, 2008.
24. Yu J, May L, Milsom C, et al: Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol 28:1975-1981, 2008.
25. Bluff JE, Brown NJ, Reed MW and Staton CA: Tissue factor, angiogenesis and tumour progression. Breast Cancer Res 10:204, 2008.
26. Hembrough TA, Swartz GM, Papathanassiu A, et al: Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 63:2997-3000, 2003. (Pubitemid 36667175)
27. Hembrough TA, Ruiz JF, Papathanassiu AE, Green SJ and Strickland DK: Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor. J Biol Chem 276:12241-12248, 2001.
28. Provencal M, Michaud M, Beaulieu E, et al: Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins. Thromb Haemost 99:576-585, 2008. (Pubitemid 351549295)
29. Kasthuri RS, Taubman MB and Mackman N: Role of tissue factor in cancer. J Clin Oncol 27:4834-4838, 2009.